Related Experiment Video
Updated: Jul 12, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Protein Corona Sensor Array Nanosystem for Detection of Coronary Artery Disease
Gha Young Lee1, Andrew A Li2, Intae Moon3
1Center for Nanomedicine, Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
Insights
A new nanoparticle-based diagnostic technology uses protein corona patterns for early coronary artery disease (CAD) detection. This non-invasive method achieves high accuracy, offering a promising tool for clinical use.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Proteomics
Background:
- Coronary artery disease (CAD) is a leading global cause of death.
- Early detection of CAD is critical for improving patient outcomes and survival rates.
Purpose of the Study:
- To develop a non-invasive diagnostic technology for early CAD detection.
- To leverage nanoparticle-protein corona interactions for disease-specific biomarker identification.
Main Methods:
- Utilized nanoparticle (NP)-based sensor array technology.
- Analyzed protein corona (PC) formation on NPs with varying physicochemical properties.
- Employed pattern recognition for disease-specific PC discrimination.
Main Results:
- The PC-based sensor array demonstrated high diagnostic performance for CAD.
- Achieved an accuracy of 92.84%, sensitivity of 87.5%, and specificity of 82.5%.
- Multivariate PC analysis across different NPs enhanced detection specificity.
Conclusions:
- The developed PC-based sensor array shows significant potential for non-invasive CAD detection.
- This technology offers a promising avenue for clinical application in cardiovascular diagnostics.
- Nanoparticle-protein corona interactions represent a valuable approach for disease biomarker discovery.
Abstract:
Coronary artery disease (CAD) is the most common type of heart disease and represents the leading cause of death in both men and women worldwide. Early detection of CAD is crucial for decreasing mortality, prolonging survival, and improving patient quality of life. Herein, a non-invasive is described, nanoparticle-based diagnostic technology which takes advantages of proteomic changes in the nano-bio interface for CAD detection. Nanoparticles (NPs) exposed to biological fluids adsorb on their surface a layer of proteins, the "protein corona" (PC). Pathological changes that alter the plasma proteome can directly result in changes in the PC. By forming disease-specific PCs on six NPs with varying physicochemical properties, a PC-based sensor array is developed for detection of CAD using specific PC pattern recognition. While the PC of a single NP may not provide the required specificity, it is reasoned that multivariate PCs across NPs with different surface chemistries, can provide the desirable information to selectively discriminate the condition under investigation. The results suggest that such an approach can detect CAD with an accuracy of 92.84%, a sensitivity of 87.5%, and a specificity of 82.5%. These new findings demonstrate the potential of PC-based sensor array detection systems for clinical use.
Related Concept Videos
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome I: Introduction

